Lv21
180 积分 2023-12-28 加入
Progressive Pulmonary Fibrosis and Interstitial Lung Abnormalities: AJR Expert Panel Narrative Review
1个月前
已完结
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Interstitial Lung Diseases: A Systematic Review and Meta-Analysis
1个月前
已完结
The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers
3个月前
已完结
Quantitative Interstitial Abnormality Progression and Outcomes in the COPDGene and PLuSS Cohorts
3个月前
已完结
Research progress of KL-6 in respiratory system diseases
3个月前
已完结
Krebs Von Den Lungen-6 As A Biomarker for Disease Severity Assessment in Interstitial Lung Disease: A Comprehensive Review
3个月前
已完结
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
3个月前
已关闭
Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management
3个月前
已完结
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
5个月前
已关闭
Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis
7个月前
已完结
皖公网安备34019202002308
